Most Read This Week
- Effects of Statin Therapy on Diagnoses of New-Onset Diabetes and Worsening Glycaemia
- ACC 2024: Semaglutide Effectively Reduces Symptoms in Obesity-Related Heart Failure
- Practical Strategies to Manage Obesity in Type 2 Diabetes
- Comparative Effects of Randomized Second-Line Therapy for Type 2 Diabetes on Glycemic Control, Body Weight, and Hypoglycemia in GRADE
- Efficacy and Safety of Tirzepatide, GLP-1 Receptor Agonists, and Other Weight Loss Drugs in Overweight and Obesity
Recently Updated
- 2011 to 2020 Saw Increase in Annual Prescription Meds Expenditures
- ACC 2024: Semaglutide Effectively Reduces Symptoms in Obesity-Related Heart Failure
- Effect of Combination Pioglitazone With SGLT2 Inhibitors or GLP-1 Receptor Agonists on Outcomes in Type 2 Diabetes
- Risk Factors for CKD in Middle Eastern Patients With Type 2 Diabetes
- Use of Rescue Insulin in the GRADE Study